Fahima Chowdhury Selected Research

Cholera Vaccines

1/2022	A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
10/2021	Systemic, Mucosal, and Memory Immune Responses following Cholera.
1/2021	A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
1/2021	Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
1/2020	Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
1/2019	Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.
1/2019	Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
1/2019	Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh.
1/2019	Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).
1/2019	Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fahima Chowdhury Research Topics

Disease

53	Cholera 01/2022 - 11/2005
31	Infections 07/2021 - 11/2004
8	Diarrhea 01/2019 - 10/2008
5	Dehydration (Water Stress) 01/2021 - 11/2009
4	Typhoid Fever (Typhoid) 11/2022 - 11/2009
2	Inflammation (Inflammations) 01/2022 - 03/2015
2	Communicable Diseases (Infectious Diseases) 01/2019 - 12/2011
2	Vomiting 09/2014 - 11/2009
2	Tuberculosis (Tuberculoses) 04/2009 - 11/2004
1	Japanese Encephalitis 11/2022
1	Shock 01/2022
1	Hepatitis A (Hepatitis, Infectious) 01/2022
1	Hepatitis B 10/2021
1	Reinfection 01/2019
1	Convalescence 01/2016

Drug/Important Bio-Agent (IBA)

21	AntigensIBA 01/2021 - 04/2008
20	Cholera Vaccines FDA Link 01/2022 - 05/2011
17	Immunoglobulin G (IgG)IBA 01/2021 - 11/2004
15	Immunoglobulin A (IgA)IBA 01/2021 - 04/2008
15	LipopolysaccharidesIBA 01/2019 - 04/2008
14	VaccinesIBA 11/2022 - 11/2008
14	Cholera ToxinIBA 01/2021 - 11/2005
10	AntibodiesIBA 01/2021 - 11/2004
8	O Antigens (O Antigen)IBA 07/2021 - 11/2012
5	shancholIBA 01/2022 - 10/2011
5	Immunoglobulin M (IgM)IBA 01/2021 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 04/2019 - 09/2009
4	Polysaccharides (Glycans)IBA 01/2022 - 06/2013
4	Blood Group Antigens (Blood Groups)IBA 01/2021 - 11/2005
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
3	EnzymesIBA 10/2013 - 10/2008
2	Conjugate VaccinesIBA 11/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2009
2	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2022 - 01/2021
2	Neuraminidase (Sialidase)IBA 01/2021 - 12/2016
2	Monoclonal AntibodiesIBA 11/2020 - 12/2016
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 03/2015
2	CytokinesIBA 03/2015 - 08/2011
2	DukoralIBA 10/2013 - 05/2011
2	Vitamin A (Retinol)FDA LinkGeneric 11/2008 - 04/2008
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 11/2022
1	TCVSIBA 11/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	ElectrolytesIBA 01/2022
1	Engerix-BIBA 10/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 10/2021
1	16S Ribosomal RNAIBA 01/2021
1	IronIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 04/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Dual OxidasesIBA 01/2018
1	InterferonsIBA 01/2018
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Oxygen (Dioxygen)IBA 05/2015
1	CarbohydratesIBA 05/2015
1	Toll-Like Receptor 4IBA 03/2015
1	CaspasesIBA 03/2015
1	InflammasomesIBA 03/2015
1	N- ((2,3- dihydro- 1,4- benzodioxin- 2- yl)methyl)- 5- methoxy- 1H- indole- 3- ethanamineIBA 11/2013
1	ImmunosorbentsIBA 10/2013
1	1-oleoyl-2-stearoylphosphatidylcholineIBA 11/2012
1	Bovine Serum AlbuminIBA 11/2012
1	4-O-carboxymethylascochlorinIBA 11/2012
1	Lewis Blood Group AntigensIBA 12/2011
1	ABO Blood-Group SystemIBA 12/2011
1	N 30IBA 05/2011
1	lipopolysaccharide AIBA 11/2009
1	MicronutrientsIBA 11/2008
1	ZincIBA 11/2008
1	Immunoglobulins (Immunoglobulin)IBA 10/2008

Therapy/Procedure

3	Therapeutics 05/2015 - 11/2004
2	Fluid Therapy (Oral Rehydration Therapy) 01/2018 - 04/2011
1	Self Administration (Administration, Self) 01/2019
1	Bathroom Equipment 01/2015
1	Chemoprevention 11/2009